Trials / Conditions / Nephrogenic Systemic Fibrosis

Nephrogenic Systemic Fibrosis

8 registered clinical trials studyying Nephrogenic Systemic Fibrosis.

Status	Trial	Sponsor	Phase
Completed	Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR NCT01135316	Lantheus Medical Imaging	—
Completed	Treatment of Patients With Nephrogenic Systemic Fibrosis With Glivec NCT00981942	University of Aarhus	Phase 3
Completed	Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis NCT00869479	Massachusetts General Hospital	—
Withdrawn	Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK I NCT00811863	Guerbet	—
Unknown	Nephrogenic Systemic Fibrosis With Gadollinum NCT01359345	Imam Khomeini Hospital	Phase 2 / Phase 3
Completed	Pilot Study of Imatinib Mesylate to Treat Nephrogenic Systemic Fibrosis NCT00677092	Massachusetts General Hospital	Phase 2
Completed	Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels NCT01014754	Northwestern University	—
Terminated	Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) NCT01078987	Loma Linda University	Phase 4